Our Mission

At AlleleRx Therapeutics, we are pioneering the first disease‑modifying therapy for Congenital Disorders of Glycosylation (CDG). We believe every child and family affected by CDG deserves:

Hope

Breakthroughs

Real solutions

Our Executive Leadership Team

Marisa Brothwell, Ph.D., M.S.

Co-founder, Chief Executive Officer

Kent Lai, Ph.D., M.B.A.

Co-founder, Chief Scientific Officer

Won Yong Lee, D.V.M., Ph.D., M.S.

Co-founder, Chief Operating Officer